As a new month begins, NutraIngredients-USA looks back at an important 31 days for the dietary supplements industry, which included a conclusion of sorts to the POM vs FTC legal battle, Sen Durbin's amendment being tabled, and clinical trial results "that cannot be ignored".
The dietary supplements industry sighed a collective sigh of relief when the Senate tabled Sen. Richard Durbin's controversial amendment to the pending Food and Drug Administration (FDA) User Fee Act.
The amendment would have required supplement formulation registration and product listing.
Copyright - Unless otherwise stated all contents of this web site are © 2017 - William Reed Business Media SAS - All Rights Reserved - Full details for the use of materials on this site can be found in the Terms & Conditions
With diabetes rates rising, many healthy people are starting to consider the effects of blood glucose levels...
We’ve had a few notable hires and promotions this month, with new hires at UAS Labs, B&D...
Immune supplement sales were valued at an impressive $2.45 billion in 2014 (Nutrition Business Journal), and in...